243 related articles for article (PubMed ID: 26272158)
1. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
3. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
4. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.
Woolbright BL; McGill MR; Yan H; Jaeschke H
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):160-7. PubMed ID: 26176423
[TBL] [Abstract][Full Text] [Related]
5. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
6. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
[TBL] [Abstract][Full Text] [Related]
7. Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: Evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro.
Gumpricht E; Dahl R; Devereaux MW; Sokol RJ
Pediatr Res; 2004 May; 55(5):814-21. PubMed ID: 14764912
[TBL] [Abstract][Full Text] [Related]
8. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
[TBL] [Abstract][Full Text] [Related]
10. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
11. Measuring Apoptosis and Necrosis in Cholestatic Liver Injury.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2019; 1981():133-147. PubMed ID: 31016652
[TBL] [Abstract][Full Text] [Related]
12. Novel insight into mechanisms of cholestatic liver injury.
Woolbright BL; Jaeschke H
World J Gastroenterol; 2012 Sep; 18(36):4985-93. PubMed ID: 23049206
[TBL] [Abstract][Full Text] [Related]
13. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
14. From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells.
Burbank MG; Sharanek A; Burban A; Mialanne H; Aerts H; Guguen-Guillouzo C; Weaver RJ; Guillouzo A
Toxicol Sci; 2017 Jun; 157(2):451-464. PubMed ID: 28369585
[TBL] [Abstract][Full Text] [Related]
15. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.
Woolbright BL; Dorko K; Antoine DJ; Clarke JI; Gholami P; Li F; Kumer SC; Schmitt TM; Forster J; Fan F; Jenkins RE; Park BK; Hagenbuch B; Olyaee M; Jaeschke H
Toxicol Appl Pharmacol; 2015 Mar; 283(3):168-77. PubMed ID: 25636263
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Zhang L; Pan Q; Zhang L; Xia H; Liao J; Zhang X; Zhao N; Xie Q; Liao M; Tan Y; Li Q; Zhu J; Li L; Fan S; Li J; Zhang C; Cai SY; Boyer JL; Chai J
Hepatology; 2023 Jun; 77(6):1866-1881. PubMed ID: 36647589
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
18. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
[TBL] [Abstract][Full Text] [Related]
19. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.
Ni X; Gao Y; Wu Z; Ma L; Chen C; Wang L; Lin Y; Hui L; Pan G
Sci Rep; 2016 Dec; 6():38694. PubMed ID: 27934920
[TBL] [Abstract][Full Text] [Related]
20. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
